Chengdu Kanghua Biological Products (300841) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Based on the latest financial reports, Chengdu Kanghua Biological Products (300841) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥92.89 Million ≈ $13.59 Million USD) by net assets (CN¥3.51 Billion ≈ $513.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300841 equity financing ratio to measure how much of total assets are equity-financed.

Chengdu Kanghua Biological Products - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Chengdu Kanghua Biological Products's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Chengdu Kanghua Biological Products earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Chengdu Kanghua Biological Products Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chengdu Kanghua Biological Products ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Janux Therapeutics Inc NASDAQ:JANX	-0.013x
Yotrio Group Co Ltd SHE:002489	-0.228x
Orient Semiconductor Electronics Ltd TW:2329	0.022x
Huadian Power International Corporation Limited F:SHX	0.012x
Clean Science and Technology Limited NSE:CLEAN	0.015x
Hebei Sailhero Environmental SHE:300137	0.020x
AirAsia X Bhd KLSE:5238	-4.848x
Central Reinsurance Corp TW:2851	0.050x

Annual Cash Flow Conversion Efficiency for Chengdu Kanghua Biological Products (2015–2024)

The table below shows the annual cash flow conversion efficiency of Chengdu Kanghua Biological Products from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Chengdu Kanghua Biological Products.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.45 Billion ≈ $504.48 Million	CN¥572.24 Million ≈ $83.74 Million	0.166x	+1.62%
2023-12-31	CN¥3.51 Billion ≈ $514.22 Million	CN¥573.98 Million ≈ $83.99 Million	0.163x	+157.64%
2022-12-31	CN¥3.08 Billion ≈ $450.07 Million	CN¥194.99 Million ≈ $28.53 Million	0.063x	+29.90%
2021-12-31	CN¥2.67 Billion ≈ $390.75 Million	CN¥130.33 Million ≈ $19.07 Million	0.049x	-73.93%
2020-12-31	CN¥1.97 Billion ≈ $288.92 Million	CN¥369.56 Million ≈ $54.08 Million	0.187x	-41.14%
2019-12-31	CN¥574.65 Million ≈ $84.09 Million	CN¥182.73 Million ≈ $26.74 Million	0.318x	+103.86%
2018-12-31	CN¥367.70 Million ≈ $53.81 Million	CN¥57.35 Million ≈ $8.39 Million	0.156x	-67.34%
2017-12-31	CN¥188.37 Million ≈ $27.56 Million	CN¥89.96 Million ≈ $13.16 Million	0.478x	+1838.25%
2016-12-31	CN¥-96.21 Million ≈ $-14.08 Million	CN¥2.64 Million ≈ $386.80K	-0.027x	+56.55%
2015-12-31	CN¥-102.87 Million ≈ $-15.05 Million	CN¥6.51 Million ≈ $951.92K	-0.063x	--

About Chengdu Kanghua Biological Products

SHE:300841 China Biotechnology

Market Cap

$878.32 Million

CN¥6.00 Billion CNY

Market Cap Rank

#9361 Global

#2331 in China

Share Price

CN¥46.19

Change (1 day)

-0.13%

52-Week Range

CN¥42.86 - CN¥92.06

All Time High

CN¥399.08